Skip to main content

Advertisement

Log in

Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer

  • Original Article
  • Published:
Gastroenterologia Japonica Aims and scope Submit manuscript

Summary

The present study was conducted to determine whether the leucocyte adherence inhibition (LAI) assay was dependent on cell-mediated immunity and whether it was of potential use in diagnosis of pancreatic cancer. The LAI response was significantly positive in 15 PPD skin-test positive individuals but it was abated by pretreatment of sensitized mononuclear cells with anti-T cell antibody (OKT3) or by depletion of monocytes. Therefore, the LAI assay is probably related to cell-mediated immunity. The LAI assay was positive in 13 of 16 patients with pancreatic cancer using pancreatic cancer extract; however, a positive reaction was not found in 11 cases of chronic pancreatitis and 10 cases of hepatocellular carcinoma. Thus, the LAI assay appears rather specific. Mononuclear cells of pancreatic and gastric cancer patients showed LAI reactivity to autologous tumor extracts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Halliday WJ, Millers: Leucocyte adherence inhibition: A simple test for cell-mediated tumor immunity and serum blocking factor. Int J Cancer 9: 477, 1972

    Article  PubMed  CAS  Google Scholar 

  2. Tataryn DN, et al: Leucocyte adherence inhibition for detecting specific tumor immunity in early pancreatic cancer. Lancet 1: 1020, 1978

    Article  PubMed  CAS  Google Scholar 

  3. Kumagai N, et al: Immunodiagnosis of pancreatic carcinoma and hepatoma by tube leucocyte adherence inhibition assay. Digestive Organ and Immunology 3: 205, 1979 (Jpn)

    Google Scholar 

  4. Matsumoto M: Leucocyte adherence inhibition test. in “Method in Immunological Experiments” No. 8, by the Japanese Society for Immunology, Kanazawa, 1975, p 2507 (Jpn)

  5. Lampert F, et al: A leucocyte adherence inhibition test for cell-mediated immunity. Klin Wschr 51: 198, 1973

    Article  PubMed  CAS  Google Scholar 

  6. Fujisawa T, et al: Leucocyte adherence inhibition by soluble tumor antigens in breast cancer patients. Cancer 39: 506, 1977

    Article  PubMed  CAS  Google Scholar 

  7. Yoshida T: Mechanism of leucocyte adherence inhibition, in “Regulatory Mechanism in Lymphocyte Activation” by David OL, New York, 1977, p 665

  8. Holt PG, et al: The LAI microtest: A rapid and sensitive procedure for the demonstration of cell-mediated immunity in vitro. J Immunol Methods 8: 277, 1975

    Article  PubMed  CAS  Google Scholar 

  9. Creemers P: The role of leucocyte subpopulations in the indirect leucocyte adherence inhibition assay in the mammary tumor virus system. Eur J Immunol 7: 48, 1977

    Article  PubMed  CAS  Google Scholar 

  10. Yu DTY, et al: Peripheral blood Ia-positive T cells: Increase in certain diseases and after immunization. J Exp Med 15: 91, 1980

    Article  Google Scholar 

  11. Ko HS, et al: Ia determinants on stimulated human T cells. J Exp Med 150: 246, 1979

    Article  PubMed  CAS  Google Scholar 

  12. Evans RL, et al: Peripheral human T cells sensitized in mixed leucocyte culture synthesize and express Ia-like antigens. J Exp Med 148: 1440, 1978

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Onji, M. Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer. Gastroenterol Jpn 19, 328–335 (1984). https://doi.org/10.1007/BF02779122

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02779122

Key Words

Navigation